Fortimicin B and process for production thereof
AssigneeAbbott Laboratories
InventorsTakashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto
Life of this patent
Estimating the term…
Abstract
A new antibiotic, Fortimicin B, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.
Claims3
A composition of matter having antibiotic activity characterized by:
- a. molecular weight of 348;
- b. molecular formula of C.sub.15 H.sub.32 N.sub.4 O.sub.5 ;
- c. an ultraviolet absorption spectrum essentially as shown in FIG. 1;
- d. an infrared absorption spectrum essentially as shown in FIG. 2;
- and
- e. a nuclear magnetic reasonance spectrum essentially as shown in FIG. 3. said composition of matter being Fortimicin B.
A process for producing the antibiotic Fortimicin B which comprises culturing a microorganism selected from the group consisting of Micromonospora olivoasterospora ATCC 21819, Micromonospora olivoasterospora ATCC 31009 and Micromonospora olivoasterospora ATCC 31010 in a nutrient medium containing assimilable sources of carbon and nitrogen at 25.degree. to 40.degree.C. and at about neutral pH until substantial antibacterial activity is detected in the culture liquor and thereafter isolating Fortimicin B.
Dependencies are inferred from the claim text.